Presented by Dr. K M J Zaki Associate Professor Department of Hepatology SOMC, Sylhet.
Improving Adherence With Simplified HAART Regimens Improving Clinical Outcomes in HIV Patients.
Computational models developed without a genotype for resource-poor countries predict response to HIV treatment with 82% accuracy AD Revell, D Wang, R.
Future Therapies of HCV Miranda Surjadi, NP San Francisco General Hospital Department of Gastroenterology/Hepatology.
AD Revell , D Wang, R Harrigan, J Gatell, L Ruiz, S Emery,
Describing the risk of an event and identifying risk factors
Www.altaweb.it/hepacivac The HCV vaccine: cooperation in the shadow of the pyramids Antonella Folgori.
Characteristics and responses to ART in the CHIPS cohort, 1996-2006 Katja Doerholt and Ali Judd on behalf of the Collaborative HIV Paediatric Study (CHIPS)
The Frontier of Research Advocacy: Hepatitis C Drug Development HIV Research Catalyst Forum Michael Carden, SUNY Downstate/Cornell Tracy Swan, Treatment.
Transmitted drug resistance Pat Cane. Questions What is the level of TDR and is it changing? Are we measuring TDR accurately? Are more sensitive methods.
L.A. Lesmana Department of Medicine, University of Indonesia, Jakarta.
Characteristics and responses to ART in the CHIPS cohort, 1996-2006